Founded: 1972
Clinicians/researchers: 200
Doctors
Research focus:
Cancer genetics and epigenetics, and cancer regulatory networks.
Clinic at-a-glance:
The Herbert Irving Comprehensive Cancer Center is a National Cancer Institute-designated comprehensive cancer center engaged in the conduct of research and the delivery of patient care. Patient care is provided in partnership with the 2,264-bed New York-Presbyterian Hospital, which U.S. News & World Report ranks as the nation’s 22nd “Best Hospital” for cancer care. Research programs cover basic, disease-specific and population-based science. The basic science component revolves largely around cancer biology — the molecular and cellular events that lead to cancer and promote its development. Patients have access to more than 200 clinical trials, many of them featuring therapeutic regimens, as well as studies designed to help understand the incidence and progression of cancer, and to improve quality of life.
